Eduardo Torres

Eduardo Torres has over 21 years of work experience in the biotechnology and pharmaceutical industry. Eduardo currently holds the position of Associate Director at both Katalytic Therapeutics and NovoMedix, starting in 2022. Prior to this, from 2016 to 2022, Eduardo worked as a scientist II at BioTheryX, Inc. and from 2018 to 2021, they held the role of Scientist II at NOVOMEDIX LLC. Before that, they served as an Associate Scientist at Celgene from 2008 to 2016. Additionally, Eduardo has experience as a Sr. Research Associate at SGX Pharmaceuticals from 2005 to 2008, a Research Associate at Neurocrine Biosciences from 2003 to 2005, a Research Assistant II at Lion Biosciences from 2000 to 2002, and a Research Assistant at Trega from 2000 to 2001.

Eduardo Torres completed their education at San Diego State University. Eduardo obtained a Bachelor's degree in Chemistry from 1994 to 2000. Later they pursued a Master's degree in Organic Chemistry from 2014 to 2016.